Weifu

Quick links to important sections

Weifu

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Weifu

Understanding Weifu

Weifu is a pharmaceutical formulation primarily used in the management of specific gastrointestinal conditions. It belongs to a class of medications designed to address imbalances in gastric acid production and to protect the mucosal lining of the digestive tract.

Mechanism of Action

The active components in Weifu work by inhibiting the biochemical processes that lead to excess acid secretion in the stomach. By reducing the acidity of gastric juices, the medication helps create an environment conducive to the healing of esophageal or gastric tissues that may have been damaged by acid reflux or inflammatory processes.

Therapeutic Intent

This medication is typically utilized to provide relief from symptoms associated with acid-related disorders. Its primary functions include:

  • Acid Neutralization and Suppression: Lowering the overall acid concentration in the stomach.
  • Mucosal Protection: Assisting in the maintenance of the protective barrier within the stomach and duodenum.
  • Symptom Management: Addressing discomfort such as heartburn and indigestion caused by gastric hyperacidity.

Composition and Characteristics

Weifu is synthesized to ensure stable delivery of its active ingredients. It is formulated to be processed by the digestive system in a manner that allows for consistent absorption, ensuring that the therapeutic levels required for acid management are maintained over a designated period. As a specialized treatment, its use is determined by clinical assessments of a patient's gastric health and specific diagnostic requirements.

What side effects are possible with Weifu?

Possible Side Effects and Safety Information

The safety profile of Weifu (Aluminum Hydroxide and Magnesium Hydroxide) is primarily characterized by effects related to its action in the gastrointestinal disorders system. Adverse reactions are classified in official regulatory documents based on frequency and system affected.

  • Uncommon effects include Constipation and Diarrhoea. These are linked to the opposing actions of the active ingredients, which typically balance each other. Other effects are listed with a Frequency Not Known, such as Abdominal pain and various Hypersensitivity reactions (e.g., pruritus or urticaria).

  • Serious Adverse Reactions: The regulatory framework documents rare but clinically significant effects, including Hypermagnesemia, classified as Very Rare in some labels, and potentially severe Anaphylactic reactions. Additionally, high doses may lead to or aggravate Intestinal obstruction or Ileus, particularly in high-risk individuals.

Population-Specific and Duration-Related Safety

Safety is strongly tied to the duration of use and specific patient conditions. The Metabolism and nutrition disorders system is the focus of serious long-term risk. Individuals with Renal Impairment are a high-risk population, as their reduced ability to clear the salts can lead to Hypermagnesemia and Hyperaluminemia.

Prolonged use is officially linked to systemic risks, including Hypophosphatemia, which can lead to complications such as Osteomalacia. Consequently, official labels contain restrictions and warnings that the medicine should not be taken in individuals with pre-existing renal failure or hypophosphatemia, or those using the maximum dosage for more than two weeks.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents classify overdose from this combination antacid primarily by its gastrointestinal effects and the potential for systemic ion toxicity in susceptible individuals, particularly over prolonged exposure.

Documented Overdose Manifestations

Reported symptoms of acute overdose with aluminum and magnesium salts include diarrhoea, abdominal pain, and vomiting. More serious complications may include the exacerbation or onset of intestinal obstruction or ileus following ingestion of large doses. Prolonged, high-dose exposure carries the risk of metabolic disturbances, such as Hypermagnesemia and Hyperaluminemia, which can lead to severe neurological or systemic effects in patients with renal impairment. The elderly are also noted as a population at higher risk for intestinal issues.

Required Emergency Action

Regulatory labeling uniformly states that in the event of accidental overdose, individuals must seek medical help or contact a Poison Control Center immediately/right away. Overdose management is officially described as symptomatic and supportive. For severe cases involving the accumulation of magnesium, the official protocol includes the administration of Intravenous Calcium Gluconate, in addition to measures such as rehydration and forced diuresis. When renal function is deficient, the label indicates that advanced clearance procedures like haemodialysis or peritoneal dialysis are necessary.

Therapeutic Uses of Weifu

Main Uses and Therapeutic Applications

Weifu is a combined pharmaceutical formulation primarily utilized in the management of gastric and duodenal disorders. It is designed to address conditions characterized by inflammation or ulceration of the upper gastrointestinal tract. The medication works through a multi-faceted approach to protect the stomach lining and facilitate the healing process of damaged tissues.

Treatment of Peptic Ulcers

The primary application of Weifu is the treatment of gastric and duodenal ulcers. By forming a protective barrier over the ulcerated area, the medication helps to shield the sensitive tissue from the corrosive effects of gastric acid and digestive enzymes. This protection allows the underlying mucosa to recover and promotes the closure of the ulcer.

Management of Gastritis

Weifu is also indicated for various forms of gastritis, including acute and chronic inflammation of the stomach lining. It assists in reducing the irritation caused by bile reflux or chemical irritants, thereby alleviating common symptoms associated with mucosal inflammation.

Benefits and Mechanisms of Action

The therapeutic benefits of Weifu stem from its ability to enhance the natural defense mechanisms of the gastrointestinal tract rather than simply suppressing acid production.

Mucosal Protection

One of the core benefits of this formulation is its mucosal protective properties. It adheres to the site of injury, creating a physical bypass that prevents further damage from hydrochloric acid. This localized action ensures that the treatment is focused where the tissue integrity has been compromised.

Promotion of Tissue Repair

Beyond simple protection, the components of Weifu are involved in stimulating the synthesis of endogenous prostaglandins. These substances are vital for maintaining the health of the stomach lining, as they improve local blood flow and encourage the secretion of bicarbonate and mucus, which serve as the body's natural buffers.

Symptomatic Relief

By addressing the underlying inflammation and protecting open sores in the digestive tract, Weifu aids in the reduction of abdominal pain, burning sensations, and discomfort associated with acid-related disorders. This leads to an overall improvement in digestive comfort during the recovery phase.

Eligibility and Restrictions for Use

Who Can and Cannot Use Weifu?

The population eligibility for Weifu (Aluminum Hydroxide/Magnesium Hydroxide) is strictly defined by regulatory authorities, focusing primarily on organ function and age.

Contraindications and Restrictions

Category Regulatory Status
Severe Renal Impairment/Kidney Disease Absolute Contraindication. Prohibited due to the severe risk of hypermagnesemia and aluminum intoxication (accumulation)

| | Hypersensitivity | Absolute Contraindication to the active ingredients or any excipients. | | Children Under 12 Years | Not Recommended for self-medication; use requires consultation with a physician as safety is not established at the adult dose. | | Prolonged Use | Use of the maximum labeled dose is restricted to 14 days or less without medical supervision. |

Eligibility is generally established for adults and children 12 years of age and older for short-term, episodic use. Caution and medical consultation are also required for individuals with moderate renal impairment, hypophosphatemia, or those who are pregnant.

What should I know about interactions with other medicines?

Weifu's officially documented interactions are primarily pharmacokinetic, stemming from its local action in the gastrointestinal tract. The medicine is documented to decrease the systemic exposure of co-administered substances through two main effects. First, chelation with aluminum and magnesium reduces the absorption of agents like iron salts, tetracyclines, and fluoroquinolones. Second, the alteration of gastric pH impacts the dissolution of certain pH-sensitive drugs, including Gabapentin and specific tyrosine kinase inhibitors. Conversely, by raising urinary pH, Weifu can increase the plasma levels of certain weak base drugs, such as Amphetamine, by reducing their renal clearance. To mitigate these effects, regulatory labels enforce a mandatory timing separation of at least two hours between administration of Weifu and many interacting medicines. Specific instructions require separating doses from Cabotegravir by 2 hours before or 4 hours after. The label includes two critical restrictions: co-administration with Deferasirox is restricted due to a documented reduction in therapeutic efficacy. Furthermore, patients with Severe Chronic Kidney Disease face an elevated risk of Magnesium accumulation (Hypermagnesemia), and for this population, the co-use of citrate-containing products is prohibited due to the risk of increased systemic aluminum toxicity.

Mechanism of Action

Wei-Fu-Chun (WFC) acts as a multi-component modulator containing multiple active constituents. The system-level effects are mediated via a network pharmacology approach involving numerous biological targets, primarily within the gastric tissue.

Key molecular actions include the modulation of several central intracellular signaling pathways. WFC and its absorbed metabolites function as inhibitors of the Mitogen-Activated Protein Kinase (MAPK) signaling cascade. Concurrently, WFC impacts the NF-kappaB pathway, leading to a modified inflammatory response. It also acts as an agonist to the 5'-Adenosine Monophosphate-activated Protein Kinase (AMPK) pathway, increasing the levels of its phosphorylated, active form. The downstream consequences of these modulations include the inhibition of cellular proliferation and migration, and the induction of apoptosis in target cells. The systemic physiological modulation results in altered gastric mucosal histology and the modification of gastric protein secretion, specifically by increasing pepsin activity.

Dosage and Administration Information

How to Use Weifu: Administration Guidelines

Weifu, a combination of Aluminum Hydroxide and Magnesium Hydroxide, is administered through the oral route for acid neutralization. The following are standard protocols for its administration.


Administration and Dosage Patterns

The medicine is available in two primary oral forms, each with specific preparation and dosing requirements:

  • Oral Suspension: The liquid must be shaken well before the dose is measured. The standard adult dose (and for children 12 years and older) typically ranges from 10 mL to 20 mL per administration. Maximum daily usage for the suspension is often restricted to 60 mL or 80 mL in a 24-hour period, depending on the concentration.

  • Chewable Tablets: Tablets must be chewed or crushed completely before swallowing to ensure proper onset of action. Taking the dose with a half glass of water or other liquid may follow for optimal administration.


Frequency, Timing, and Duration

Weifu is typically taken on an as-needed basis for symptomatic episodes. Dosing is often scheduled to occur between meals and at bedtime to manage symptoms related to stomach acidity. The standard frequency permits doses to be taken up to four times a day (QID). A crucial instruction is the duration constraint: use of the maximum dosage should not exceed two weeks unless specific guidance is provided by a physician. The product is not intended for long-term daily maintenance.


Use in Specific Populations

Administration rules for specific groups include the following:

  • Pediatric Patients: Weifu is used in children 12 years of age and older. For children under 12 years, consultation with a physician is required prior to administration.

  • Kidney Impairment: Patients with known kidney disease or those on a magnesium-restricted diet must consult a physician before use, as the magnesium component requires careful consideration in this context.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Weifu

Evidence for Relief of Occasional Heartburn and Acid Indigestion

The primary research for Weifu was studied for its use in addressing short-term discomfort related to excess stomach acid, such as heartburn (pyrosis) and acid indigestion. The combination of active ingredients was studied for use in research exploring how symptoms change over time when conditions characterized by fluctuating or episodic manifestations occur. These findings contribute to the broader evidence landscape used in regulatory review of over-the-counter antacids, with studies monitoring the direct chemical neutralization of acid.

Studies conducted during periods of increased symptom activity include short-term randomized controlled trials (RCTs). These trials explored outcomes related to physical discomfort and outcomes reflecting episodic or acute changes. Research examined patient-reported outcomes describing perceived discomfort, such as the time elapsed until symptom change and the duration of the acid buffering that studies monitored. The evidence provides limited data on the management of long-term acid-related disease, as the results apply only to the immediate symptomatic patterns studied.


Study Outcomes: Measuring Relief and Acid Neutralization

Researchers monitored two main types of outcomes in studies observing responses over defined time intervals. The first type involves physiological outcomes, where studies monitored changes in gastric pH levels to assess the medicine’s acid-neutralizing capacity (ANC). These data show patterns related to the magnitude of acid buffering by the ingredients in the stomach environment. The second set of outcomes includes patient-reported outcomes, focusing on changes in burning sensations and general sour stomach. Research has explored outcomes capturing phases of heightened symptom activity, and findings describe patterns observed in the studies regarding the speed of symptom change.


Limitations and Research Gaps

A key limitation is that the research base was predominantly studied for symptomatic relief rather than exploring outcomes linked to disease modification. Data for long-term outcomes are not fully established because research exploring short-term symptom changes has been the primary focus. Comparative evidence is lacking against some prescription therapies for chronic use. The data are still emerging regarding long-term outcomes, and study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies
  2. Antacids revisited: review on contemporary facts and relevance for self-management

Frequently Asked Questions (FAQ)

Common questions about Weifu (FAQ)

Q: What is the main difference between Weifu and other common treatments for the same condition?

According to official documentation, Weifu is classified as a non-systemic antacid. Official classification describes its function as local neutralization of acid already present in the stomach. This approach differs from other treatments, such as H2 receptor blockers or Proton Pump Inhibitors (PPIs), which work by reducing the overall production of stomach acid.

Q: How long after starting Weifu should a person typically expect to notice its effects?

Official product information indicates that Weifu provides symptomatic relief. Due to its local action in the stomach, relief is typically prompt.

Q: Does Weifu contain any common allergens like gluten or lactose?

The official product label lists all inactive ingredients used in the formulation, which may differ slightly between the liquid and tablet forms. Official guidelines recommend reviewing the inactive ingredient list on the container for specific allergens like gluten or lactose.

Q: Can Weifu be taken with common over-the-counter pain relievers?

Weifu has the potential to interact with many medications by reducing their absorption in the digestive tract. Official documentation indicates the necessity of reviewing the full list of potential interactions for any co-administered medicine.

Q: What is the risk of dependence or addiction associated with Weifu?

Weifu is classified as an Over-the-Counter (OTC) medicine. It is officially documented as Not a controlled substance, which means official documents do not associate it with a risk of dependence or addiction.

Q: Is it common to feel tired when first starting Weifu?

Fatigue or tiredness is not listed among the common or uncommon side effects in official regulatory documents. However, rare, serious effects associated with magnesium accumulation are documented to include symptoms such as drowsiness, particularly in high-risk individuals.

Q: Is there a generic version of Weifu available?

Regulatory information indicates that the active ingredients used in Weifu (Aluminum Hydroxide and Magnesium Hydroxide) are widely available. These ingredients are marketed in various over-the-counter products under both generic names and multiple brand names.

Q: Does taking Weifu require any specific monitoring by a healthcare provider?

For general short-term use, official documents do not typically specify routine monitoring. However, for patients on prolonged use of the medication or those with known kidney impairment, official documents note that monitoring by a healthcare provider may be indicated for kidney function and blood plasma concentrations.

Q: What are the known potential effects of Weifu on sleep?

Effects on sleep are noted in regulatory documents as potential rare side effects, primarily linked to serious events. Rare instances of magnesium accumulation are documented to potentially cause symptoms like drowsiness or deep sleep.

Q: What does the research say about the long-term use of Weifu?

Official product restrictions state that use of the maximum dosage is limited to 14 days or less without specific physician oversight due to potential systemic risks. The available research primarily supports the product’s use for short-term symptomatic relief, and long-term safety data are not fully established.

Q: Does Weifu affect a person's ability to drive or operate machinery?

Official warnings note that potential rare side effects associated with the medication, such as drowsiness or confusion (especially in high-risk individuals), may affect alertness. Due to these potential effects, official warnings advise caution before engaging in activities requiring full alertness.

Q: What is the shelf life of Weifu?

The official shelf life of the product is determined by the manufacturer and is indicated by the expiration date. This date is printed directly on the product's container label, as required by regulatory standards.

Q: Is Weifu available in different forms (e.g., tablet, liquid)?

Official documentation indicates that the medicine is manufactured and made available in two primary oral forms: an Oral Suspension (liquid) and Chewable Tablets.

Q: How common are serious side effects from Weifu?

The most serious adverse reactions, such as severe magnesium accumulation (Hypermagnesemia) or Anaphylactic reactions, are officially classified as Very Rare in some regulatory labels. These effects are classified as Very Rare and official warnings identify them primarily in high-risk groups, such as those with kidney impairment.

Q: Do I need to take Weifu at a specific time of day?

The medicine is typically taken on an as-needed basis for symptoms, with official labeling describing common timing as occurring between meals and at bedtime to manage symptoms related to stomach acidity.

Q: If I miss a dose of Weifu, what is the general guidance?

The product is administered on an as-needed basis for symptomatic relief. Official regulatory documents do not provide specific guidance regarding how to handle a missed dose, as the product is typically used only when symptoms occur.

Q: Does Weifu interact with birth control pills?

Weifu has the potential to interact with many oral medications by reducing their absorption. While birth control pills are not specifically listed among the mandatory key warnings in the product label, patients taking oral contraceptives or any other prescription drug should review the full list of potential interactions.

Q: Can a person stop taking Weifu suddenly, or does it need to be tapered off?

The product is administered on an as-needed basis for symptomatic relief. Official regulatory documents do not contain any instructions for tapering off the medication.

Q: Can Weifu be split, crushed, or chewed?

The administration guidelines differ based on the form. Regulatory instructions mandate that the chewable tablets must be chewed or crushed completely before swallowing. The oral suspension (liquid) must be shaken well before the dose is measured.

How should Weifu be stored and disposed of?

Storage Requirements

Weifu (Aluminum Hydroxide and Magnesium Hydroxide) must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F), as specified in official labeling. The medicine should be protected from excessive heat and moisture, and the oral suspension formulation must be protected from both freezing and light.

All medicines must be kept in the container they were provided in, with the container maintained tightly closed. A critical safety requirement is that Weifu must be stored out of the sight and reach of children.

Disposal Instructions

The preferred method for discarding unused or expired Weifu is through an authorized drug take-back program. If a take-back program is not available, the medicine should not be flushed down the toilet. Instead, it should be removed from the container, mixed with an undesirable substance (such as dirt), and placed in a sealed bag before being disposed of in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Weifu found in:

A-Z Index: